DoW Ovarian Cancer, Clinical Trial Award
Funds clinical trials of ovarian cancer drugs, biologics, devices or guidance, from small pilots to large efficacy studies.
About
A promising ovarian cancer idea still has to prove itself in people, and it has to do so at whatever scale honestly matches the evidence behind it so far. This award funds that step directly.
What is funded is the rapid implementation of clinical trials with the potential to meaningfully change how ovarian cancer is treated or managed. Trials can evaluate promising new products, pharmacologic age…
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.